Beam Therapeutics BEAM
$20.90 −$0.04 (-0.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $21.66 +3.65%
Open$20.60
Prev close$20.94
Day range$20.54 – $22.10
Volume3.89M
Market cap$2.16B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$307,000.00-96.8% YoY
Operating profit-$141.32M-11.4% YoY
Net profit-$134.41M-19.4% YoY
Diluted EPS-$1.28-16.4% YoY
Free cash flow-$111.96M-29.4% YoY
Operating cash flow-$110.75M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Operating margin-267.7%
Net margin-73.9%
Return on equity-11.3%
Return on assets-8.4%
Return on invested capital-9.4%
Current ratio13.00
Liabilities / assets24.9%
Cash & investments$1.04B
Total debt$228.23M
Net cash (debt)$815.65M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $307,000.00 | $490,000.00 | $31.74M | $139.74M | $114.11M |
| Total Operating Revenue | $307,000.00 | $490,000.00 | $31.74M | $139.74M | $114.11M |
| Operating Expense | $141.63M | $127.04M | $138.95M | $523.44M | $131.55M |
| Selling and Admin Expenses | $31.52M | $31.95M | $34.43M | $113.82M | $32.28M |
| -General & Admin Expense | $31.52M | $31.95M | $34.43M | $113.82M | $32.28M |
| Research & Development | $110.11M | $95.10M | $104.52M | $409.62M | $99.28M |
| Operating Profit | -$141.32M | -$126.55M | -$107.22M | -$383.69M | -$17.45M |
| Net Non-Operating Interest Income (Expense) | $6.09M | $7.49M | $9.87M | $43.73M | $10.64M |
| Total Other Finance Costs | -$6.09M | -$7.49M | -$9.87M | -$43.73M | -$10.64M |
| Other Income (Expense) | $823,000.00 | -$4.07M | $3.03M | $259.97M | $249.85M |
| Gain on Sale of Security | $3.68M | -$3.86M | $2.52M | $4.64M | -$4.53M |
| Special Income (Charges) | -$2.86M | -$205,000.00 | $514,000.00 | $180,000.00 | -$765,000.00 |
| -Less:Restructuring and Mergern & Acquisition | $2.86M | $205,000.00 | -$514,000.00 | -$180,000.00 | $765,000.00 |
| Pretax Profit | -$134.41M | -$123.13M | -$94.32M | -$79.99M | $243.05M |
| $0.00 | – | – | – | – | |
| Net Profit | -$134.41M | -$122.68M | -$94.32M | -$79.99M | $243.05M |
| Profit from Continuing Operations | -$134.41M | -$122.68M | -$94.32M | -$79.99M | $243.05M |
| Net Income to Parent Company | -$134.41M | -$122.68M | -$94.32M | -$79.99M | $243.05M |
| Net Income to Common Stockholders | -$134.41M | -$122.68M | -$94.32M | -$79.99M | $243.05M |
| Basic EPS | -$1.28 | -$1.18 | -$0.91 | -$0.81 | $2.37 |
| Diluted EPS | -$1.28 | -$1.18 | -$0.91 | -$0.81 | $2.33 |
| Tax | – | -$455,000.00 | – | $0.00 | $0.00 |
| Earnings from Equity Interest | – | – | – | $255.15M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.27B | $1.39B | $1.48B | $1.48B | $1.48B |
| Total Current Assets | $1.07B | $1.18B | $1.27B | $1.27B | $1.27B |
| Cash and Cash Equivalents & Short-Term Investments | $1.04B | $1.15B | $1.21B | $1.25B | $1.25B |
| -Cash and Cash Equivalents | $213.27M | $219.83M | $288.29M | $294.94M | $294.94M |
| -Short Term Investments | $830.61M | $933.10M | $923.36M | $950.27M | $950.27M |
| Other Current Assets | $23.50M | $25.67M | $55.30M | $23.48M | $23.48M |
| Total Non-Current Assets | $201.70M | $207.76M | $213.85M | $212.49M | $212.49M |
| Net PPE | $187.03M | $193.19M | $199.40M | $205.18M | $205.18M |
| -Gross PPE | $297.20M | $298.00M | $299.13M | $299.31M | $299.31M |
| -Accumulated Depreciation | -$110.17M | -$104.81M | -$99.73M | -$94.13M | -$94.13M |
| Other Non-Current Assets | $14.66M | $14.57M | $14.45M | $7.31M | $7.31M |
| Total Liabilities | $316.40M | $318.91M | $316.36M | $242.82M | $242.82M |
| Total Current Liabilities | $82.08M | $80.88M | $74.57M | $96.94M | $96.94M |
| Payables | $20.15M | $13.10M | $12.29M | $10.23M | $10.23M |
| -Accounts Payable | $20.15M | $13.10M | $12.29M | $10.23M | $10.23M |
| Current Accrued Expenses | $16.17M | $17.28M | $23.46M | $23.94M | $23.94M |
| Short-Term Debt and Capital Lease Obligation | $15.65M | $15.21M | $14.78M | $14.36M | $14.36M |
| -Current Capital Lease Obligation | $15.65M | $15.21M | $14.78M | $14.36M | $14.36M |
| Current Deferred Liabilities | $0.00 | $0.00 | $304,000.00 | $6.66M | $6.66M |
| Other Current Liabilities | $11.25M | $21.23M | $17.06M | $12.40M | $12.40M |
| Total Non-Current Liabilities | $234.32M | $238.03M | $241.80M | $145.88M | $145.88M |
| Long Term Debt and Capital Lease Obligation | $228.23M | $232.15M | $236.04M | $139.76M | $139.76M |
| -Long Term Debt | $100.36M | $100.26M | $100.19M | – | – |
| -Long Term Capital Lease Obligation | $127.86M | $131.89M | $135.85M | $139.76M | $139.76M |
| Other Non-Current Liabilities | $6.10M | $5.88M | $5.75M | $6.13M | $6.13M |
| Total Equity | $952.67M | $1.07B | $1.16B | $1.24B | $1.24B |
| Stockholders' Equity | $952.67M | $1.07B | $1.16B | $1.24B | $1.24B |
| Capital Stock | $1.03M | $1.03M | $1.03M | $1.02M | $1.02M |
| -Common Stock | $1.03M | $1.03M | $1.03M | $1.02M | $1.02M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $2.95B | $2.93B | $2.90B | $2.88B | $2.88B |
| Retained Earnings | -$1.99B | -$1.86B | -$1.74B | -$1.64B | -$1.64B |
| Gains/Losses Not Affecting Retained Earnings | -$3.43M | -$2.19M | -$1.07M | $1.11M | $1.11M |
| Derivative Product Liabilities | – | – | – | $0.00 | $0.00 |
| Non-Current Deferred Liabilities | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$110.75M | -$66.10M | -$128.51M | -$345.10M | -$83.29M |
| Net cash flow from continuing operations | -$110.75M | -$66.10M | -$128.51M | -$345.10M | -$83.29M |
| Net Income from Continuing Operations | -$134.41M | -$122.68M | -$94.32M | -$79.99M | $243.05M |
| Gain/Loss from Continuing Operations | -$4.70M | $3.79M | -$2.50M | -$255.45M | -$253.95M |
| Depreciation & Depletion & Amortization | $5.45M | $5.41M | $5.61M | $22.29M | $5.67M |
| Other Non-Cash Items | $5.56M | $2.83M | $2.05M | $24.72M | $3.28M |
| Change in Working Capital | $620,000.00 | $28.22M | -$55.62M | -$131.02M | -$101.86M |
| -Change in Prepaid Assets | $2.07M | $29.53M | -$31.86M | $4.51M | $59,000.00 |
| -Change in Payables and Accrued Expense | $2.07M | $2.53M | -$14.04M | $13.73M | $15.49M |
| -Change in Other Current Liabilities | -$3.52M | -$3.54M | -$3.36M | -$13.84M | -$3.59M |
| -Change In Other Working Capital | $0.00 | -$304,000.00 | -$6.36M | -$135.42M | -$113.82M |
| Net cash flow from investing | $101.86M | -$9.88M | $25.27M | -$121.44M | $108.41M |
| Net Cash Flow from Continuing Investing Activities | $101.86M | -$9.88M | $25.27M | -$121.44M | $108.41M |
| Net PPE Purchase and Sale | -$1.21M | -$2.41M | -$2.23M | -$14.95M | -$3.73M |
| Net Business Purchase and Sale | $0.00 | – | – | $255.07M | $255.15M |
| Net Investment Purchase and Sale | $103.07M | -$7.92M | $27.50M | -$361.56M | -$143.01M |
| Financing Cash Flow | $2.33M | $7.52M | $96.61M | $478.05M | $1.89M |
| Net Cash Flow from Continuing Financing Activities | $2.33M | $7.52M | $96.61M | $478.05M | $1.89M |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | $93.89M | $0.00 | $0.00 |
| Net Common Stock Issuance | $0.00 | $0.00 | $0.00 | $470.51M | $0.00 |
| Proceeds from Stock Option Exercised | $2.33M | $7.52M | $3.54M | $7.54M | $1.89M |
| Net Other Financing Charges | $0.00 | $0.00 | -$813,000.00 | – | – |
| Ending Cash Balance | $219.97M | $226.54M | $294.98M | $301.62M | $301.62M |
| Net Change in Cash | -$6.56M | -$68.45M | -$6.64M | $11.51M | $27.00M |
| Beginning Cash Balance | $226.54M | $294.98M | $301.62M | $290.11M | $274.62M |
| Free Cash Flow | -$111.96M | -$68.51M | -$130.75M | -$360.05M | -$87.02M |
No comments yet — be the first to weigh in on BEAM.
Sign in to join the discussion.